PP
Prof. Pierre J. Magistretti, MD, PhD
Scientific Founder, Chairman of the Scientific Advisory Board
GliaPharmTherapeutic Areas
GliaPharm Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lead Program (undisclosed) | Alzheimer's Disease | Preclinical |
| Epilepsy Program | GLUT1 Deficiency Syndrome (Epilepsy) | Preclinical |
| ALS Research | Amyotrophic Lateral Sclerosis | Research |